New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
10:18 EDTIDTI, MTH, AES, KMX, EMR, PE, TYC, PNK, MCRS, VVUSHigh option volume stocks
High option volume stocks: AES MCRS PE MTH PNK EMR IDTI TYC KMX VVUS
News For AES;MCRS;PE;MTH;PNK;EMR;IDTI;TYC;KMX;VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 4, 2015
10:01 EDTKMXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:02 EDTKMXCarMax downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
07:14 EDTPESimmons to hold a conference
Subscribe for More Information
March 3, 2015
16:52 EDTMTHMeritage Homes files automatic mixed securities shelf
Subscribe for More Information
11:25 EDTVVUSOrexigen surges after disclosing weight loss drug data, patent news
Shares of Orexigen (OREX) are surging in morning trading after the company disclosed the data from the 25% interim analysis of the LIGHT cardiovascular study when announcing a method of treatment patent was issued for its weight loss drug, Contrave. In the filing, the company disclosed that Contrave demonstrated a statistically significant benefit over placebo for cardiovascular events, including CV death. ANALYST OPINION: The new patent announced today extends protection for Contrave to 2034, analysts at Piper Jaffray stated. The firm thinks the new data could possibly drive a competitive advantage in the U.S. market for Contrave, and enhance probability of approvals outside the U.S. It kept an Overweight rating on Orexigen and raised its price target on the stock to $26 from $16. Meanwhile, Leerink noted the data show a statistically significant Contrave benefit in the intent-to-treat population on MACE, myocardial infarction, stroke, and cardiovascular death. The firm believes the results "present meaningful upside to expectations" and could have a positive impact on the Contrave launch if they are included on the drug's labels. Leerink reiterates an Outperform rating on Orexigen. OTHERS TO WATCH: Other companies that offer weight loss drugs that compete with Contrave include VIVUS (VVUS) and Arena Pharmaceuticals (ARNA). PRICE ACTION: In morning trading, Orexigen shares surged 44.5% to $8.37, VIVUS shares rose 8% to $2.99 and Arena slid 3.5% to $4.13.
March 2, 2015
05:50 EDTIDTIIntegrated Device power transmitter adopted by Samsung
Subscribe for More Information
February 26, 2015
16:53 EDTPEParsley Energy reports Q4 EPS ex-items 2c, consensus 9c
Reports Q4 revenue $78.1M, consensus $88.64M. Parsley has issued 2015 production guidance of 18.0-19.0 MBoe/d, representing 30% growth at the midpoint relative to 2014 average daily production of 14.2 MBoe/d. The outlook for 2015 incorporates the effect of winter storms that hindered drilling and production in January. In 2015, the company plans to spend between $195M-$210M on drilling and completion activities and between $30M-$40M on infrastructure and other items, representing total development capital expenditures of $225M-$250M.
11:34 EDTIDTIIntegrated Device management to meet with Stephens
Subscribe for More Information
06:13 EDTAESAES Corp. sees FY17-FY18 adjusted EPS 6%-8% growth
Subscribe for More Information
06:12 EDTAESAES Corp. sees FY16 adjusted EPS to be flat to modest growth
Subscribe for More Information
06:12 EDTAESAES Corp cuts FY15 adjusted EPS to $1.25-$1.35 from $1.30-$1.40, consensus $1.28
Subscribe for More Information
06:10 EDTAESAES Corp. board announces $400M share repurchase authorization
Subscribe for More Information
06:10 EDTAESAES Corp. reports Q4 adjusted EPS 41c, consensus 36c
Reports Q4 revenue $4.13B, consensus $5.21B
February 24, 2015
16:01 EDTVVUSVIVUS reports Q4 EPS (25c), consensus (25c)
Reports Q4 revenue $21.7M, consensus $20.01M.
09:18 EDTEMREmerson says concerned with strong dollar, decline in oil prices
Subscribe for More Information
09:17 EDTEMREmerson reports orders fell 10%-5% in 3 month period end January
Subscribe for More Information
09:16 EDTEMREmerson negative order growth not a surprise, says Wells Fargo
Subscribe for More Information
08:34 EDTMTHMeritage Homes reports 606 home orders in January
Meritage Homes is providing certain details regarding the companyís total home orders for the month of January. Orders for 606 homes in January were 48% greater than the 409 orders for January 2014, resulting from a 20% increase in average orders per community and a 24% increase in average actively selling communities. All three operating regions increased January home orders and average orders per community: West region orders increased 39% with a 31% increase in average orders per community; Central region orders increased 6% with a 22% increase in average orders per community, including a 15% increase in Houstonís average orders per community; East region orders increased 146%, primarily due to the addition of Atlanta and Greenville markets in August 2014, combined with increased orders per community for Florida, Tennessee and North Carolina.
February 23, 2015
10:19 EDTIDTIIntegrated Device management to meet with Craig Hallum
Meetings to be held in Canada on February 24, in Chicago on February 25 and in San Francisco on February 26 hosted by Craig Hallum.
February 20, 2015
15:23 EDTMTHMeritage Homes management to meet with JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use